Targeting Notch signaling by γ-secretase inhibitor I enhances the cytotoxic effect of 5-FU in gastric cancer

[1]  H-W Lee,et al.  Activation of nuclear PTEN by inhibition of Notch signaling induces G2/M cell cycle arrest in gastric cancer , 2016, Oncogene.

[2]  Seok-Jun Kim,et al.  Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer , 2015, Oncotarget.

[3]  Kyung-Hee Chun,et al.  Glucose Deprivation Triggers Protein Kinase C-dependent β-Catenin Proteasomal Degradation , 2015, The Journal of Biological Chemistry.

[4]  Seok-Jun Kim,et al.  Galectin-3 activates PPARγ and supports white adipose tissue formation and high-fat diet-induced obesity. , 2015, Endocrinology.

[5]  J. Cheong,et al.  Celastrol inhibits gastric cancer growth by induction of apoptosis and autophagy , 2014, BMB reports.

[6]  I. Choi,et al.  Ablation of galectin-3 induces p27KIP1-dependent premature senescence without oncogenic stress , 2014, Cell Death and Differentiation.

[7]  T. Irimura,et al.  Up-regulation of neogenin-1 increases cell proliferation and motility in gastric cancer , 2014, Oncotarget.

[8]  Hugo J. Bellen,et al.  Notch Signaling , 2014, Methods in Molecular Biology.

[9]  J. Ro,et al.  Galectin-7 is epigenetically-regulated tumor suppressor in gastric cancer , 2013, Oncotarget.

[10]  I. Choi,et al.  Acceleration of Gastric Tumorigenesis Through MKRN1-Mediated Posttranslational Regulation of p14ARF , 2012, Journal of the National Cancer Institute.

[11]  T. Satoh,et al.  S-1 for the treatment of gastrointestinal cancer , 2012, Expert opinion on pharmacotherapy.

[12]  F. Ciardiello,et al.  Current status of targeted therapies in advanced gastric cancer , 2012, Expert opinion on therapeutic targets.

[13]  Seok-Jun Kim,et al.  Galectin-3 increases the motility of mouse melanoma cells by regulating matrix metalloproteinase-1 expression , 2012, Experimental & Molecular Medicine.

[14]  Ji‐Young Shin,et al.  STAT3 silencing enhances the efficacy of the HSV.tk suicide gene in gastrointestinal cancer therapy , 2012, Clinical & Experimental Metastasis.

[15]  M. Evgen’ev,et al.  Parallelism and paradoxes on viability and the life span of two loss-of-function mutations: Heat shock protein transcriptional regulator hsf1 and l(2)gl tumor suppressor in Drosophila melanogaster , 2012, Biology Bulletin.

[16]  Y. Bae,et al.  MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7 , 2012, Breast Cancer Research.

[17]  Seok-Jun Kim,et al.  Development of microRNA-145 for therapeutic application in breast cancer. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[18]  S. Gygi,et al.  A SIRT1-LSD1 corepressor complex regulates Notch target gene expression and development. , 2011, Molecular cell.

[19]  B. Langlois,et al.  LRP-1 Promotes Cancer Cell Invasion by Supporting ERK and Inhibiting JNK Signaling Pathways , 2010, PloS one.

[20]  V. Orian-Rousseau.  CD44, a therapeutic target for metastasising tumours. , 2010, European journal of cancer.

[21]  Ji‐Young Shin,et al.  Silencing of galectin‐3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents , 2010, Cancer science.

[22]  M. Kuo,et al.  The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2. , 2009, Cancer research.

[23]  A. Ferrando,et al.  Oncogenic NOTCH1 Control of MYC and PI3K: Challenges and Opportunities for Anti-NOTCH1 Therapy in T-Cell Acute Lymphoblastic Leukemias and Lymphomas , 2008, Clinical Cancer Research.

[24]  U. Lendahl,et al.  Notch signaling mediates hypoxia-induced tumor cell migration and invasion , 2008, Proceedings of the National Academy of Sciences.

[25]  A. Ferrando,et al.  The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia , 2008, Cell cycle.

[26]  Jian Zhang,et al.  Notch signaling regulates the FOXP3 promoter through RBP-J- and Hes1-dependent mechanisms , 2008, Molecular and Cellular Biochemistry.

[27]  J. Ajani,et al.  Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  G. Lockwood,et al.  High-level JAG1 mRNA and protein predict poor outcome in breast cancer , 2007, Modern Pathology.

[29]  Ali H. Brivanlou,et al.  Signaling Pathways in Cancer and Embryonic Stem Cells , 2007, Stem Cell Reviews.

[30]  I. Shih,et al.  Notch Signaling, γ-Secretase Inhibitors, and Cancer Therapy: Figure 1. , 2007 .

[31]  D. Srivastava,et al.  Hrt and Hes negatively regulate Notch signaling through interactions with RBP-Jkappa. , 2006, Biochemical and biophysical research communications.

[32]  Tian-Li Wang,et al.  Notch3 gene amplification in ovarian cancer. , 2006, Cancer research.

[33]  F. Alt,et al.  Activating Notch1 mutations in mouse models of T-ALL. , 2005, Blood.

[34]  A. Knowlton,et al.  NFκB, heat shock proteins, HSF-1, and inflammation , 2006 .

[35]  A. Knowlton,et al.  NFkappaB, heat shock proteins, HSF-1, and inflammation. , 2006, Cardiovascular research.

[36]  L. L. Reed,et al.  Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi's sarcoma tumor cells , 2005, Oncogene.

[37]  G. Lockwood,et al.  High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. , 2005, Cancer research.

[38]  S. Varambally,et al.  JAGGED1 Expression Is Associated with Prostate Cancer Metastasis and Recurrence , 2004, Cancer Research.

[39]  Jay S. Fine,et al.  Chronic Treatment with the γ-Secretase Inhibitor LY-411,575 Inhibits β-Amyloid Peptide Production and Alters Lymphopoiesis and Intestinal Cell Differentiation* , 2004, Journal of Biological Chemistry.

[40]  G. Higgins,et al.  Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. , 2004, The Journal of biological chemistry.

[41]  M. Fortini,et al.  Signalling: γ-Secretase-mediated proteolysis in cell-surface-receptor signalling , 2002, Nature Reviews Molecular Cell Biology.

[42]  R. Dai,et al.  Heat shock factor‐4 (HSF‐4a) is a repressor of HSF‐1 mediated transcription * , 2001, Journal of cellular biochemistry.

[43]  G. Hahn,et al.  Analysis of HSF-1 phosphorylation in A549 cells treated with a variety of stresses. , 1994, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.